AVP and metabolic syndrome: Moreover, recent studies indicate that higher concentrations of AVP or copeptin predispose patients to the development of type 2 diabetes and metabolic syndrome and that the consumption of larger amounts of water by people with high plasma copeptin concentrations results in a reduction in fasting glucose or glucagon levels [188].